Medical - Instruments & Supplies
Compare Stocks
2 / 10Stock Comparison
POCI vs COHR
Revenue, margins, valuation, and 5-year total return — side by side.
Hardware, Equipment & Parts
POCI vs COHR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Instruments & Supplies | Hardware, Equipment & Parts |
| Market Cap | $37M | $50.62B |
| Revenue (TTM) | $22M | $1.81T |
| Net Income (TTM) | $-6M | $191.68B |
| Gross Margin | 15.0% | 0.1% |
| Operating Margin | -27.3% | 0.0% |
| Forward P/E | — | 61.6x |
| Total Debt | $2M | $3.89B |
| Cash & Equiv. | $2M | $909M |
POCI vs COHR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Precision Optics Co… (POCI) | 100 | 109.3 | +9.3% |
| Coherent, Inc. (COHR) | 100 | 705.4 | +605.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: POCI vs COHR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
POCI is the clearest fit if your priority is income & stability and sleep-well-at-night.
- beta 0.41
- Lower volatility, beta 0.41, Low D/E 16.6%, current ratio 1.64x
- Beta 0.41, current ratio 1.64x
COHR carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 23.4%, EPS growth 71.7%, 3Y rev CAGR 20.5%
- 14.7% 10Y total return vs POCI's 251.9%
- 23.4% revenue growth vs POCI's -0.1%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 23.4% revenue growth vs POCI's -0.1% | |
| Quality / Margins | 10.6% margin vs POCI's -28.3% | |
| Stability / Safety | Beta 0.41 vs COHR's 2.79, lower leverage | |
| Dividends | 0.0% yield; the other pay no meaningful dividend | |
| Momentum (1Y) | +358.5% vs POCI's +6.3% | |
| Efficiency (ROA) | 4.4% ROA vs POCI's -27.3%, ROIC 3.6% vs -32.5% |
POCI vs COHR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
POCI vs COHR — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
COHR leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
COHR is the larger business by revenue, generating $1.81T annually — 83913.5x POCI's $22M. COHR is the more profitable business, keeping 10.6% of every revenue dollar as net income compared to POCI's -28.3%. On growth, COHR holds the edge at +1204.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $22M | $1.81T |
| EBITDAEarnings before interest/tax | -$6M | $913M |
| Net IncomeAfter-tax profit | -$6M | $191.7B |
| Free Cash FlowCash after capex | -$4M | -$537.2B |
| Gross MarginGross profit ÷ Revenue | +15.0% | +0.1% |
| Operating MarginEBIT ÷ Revenue | -27.3% | +0.0% |
| Net MarginNet income ÷ Revenue | -28.3% | +10.6% |
| FCF MarginFCF ÷ Revenue | -17.0% | -29.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +59.2% | +1204.5% |
| EPS Growth (YoY)Latest quarter vs prior year | 0.0% | +11190.8% |
Valuation Metrics
POCI leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $37M | $50.6B |
| Enterprise ValueMkt cap + debt − cash | $37M | $53.6B |
| Trailing P/EPrice ÷ TTM EPS | -5.59x | -613.83x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 61.57x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 48.61x |
| Price / SalesMarket cap ÷ Revenue | 1.92x | 8.71x |
| Price / BookPrice ÷ Book value/share | 2.63x | 5.83x |
| Price / FCFMarket cap ÷ FCF | — | 262.58x |
Profitability & Efficiency
COHR leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
COHR delivers a 6.9% return on equity — every $100 of shareholder capital generates $7 in annual profit, vs $-56 for POCI. POCI carries lower financial leverage with a 0.17x debt-to-equity ratio, signaling a more conservative balance sheet compared to COHR's 0.46x. On the Piotroski fundamental quality scale (0–9), COHR scores 7/9 vs POCI's 3/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -55.9% | +6.9% |
| ROA (TTM)Return on assets | -27.3% | +4.4% |
| ROICReturn on invested capital | -32.5% | +3.6% |
| ROCEReturn on capital employed | -43.3% | +4.2% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 7 |
| Debt / EquityFinancial leverage | 0.17x | 0.46x |
| Net DebtTotal debt minus cash | $262,685 | $3.0B |
| Cash & Equiv.Liquid assets | $2M | $909M |
| Total DebtShort + long-term debt | $2M | $3.9B |
| Interest CoverageEBIT ÷ Interest expense | -28.85x | 0.01x |
Total Returns (Dividends Reinvested)
COHR leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in COHR five years ago would be worth $50,156 today (with dividends reinvested), compared to $9,205 for POCI. Over the past 12 months, COHR leads with a +358.5% total return vs POCI's +6.3%. The 3-year compound annual growth rate (CAGR) favors COHR at 114.9% vs POCI's -7.8% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +11.8% | +64.3% |
| 1-Year ReturnPast 12 months | +6.3% | +358.5% |
| 3-Year ReturnCumulative with dividends | -21.7% | +892.8% |
| 5-Year ReturnCumulative with dividends | -7.9% | +401.6% |
| 10-Year ReturnCumulative with dividends | +251.9% | +1467.0% |
| CAGR (3Y)Annualised 3-year return | -7.8% | +114.9% |
Risk & Volatility
Evenly matched — POCI and COHR each lead in 1 of 2 comparable metrics.
Risk & Volatility
POCI is the less volatile stock with a 0.41 beta — it tends to amplify market swings less than COHR's 2.79 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. COHR currently trades 87.5% from its 52-week high vs POCI's 78.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.42x | 2.82x |
| 52-Week HighHighest price in past year | $6.04 | $364.80 |
| 52-Week LowLowest price in past year | $3.55 | $67.30 |
| % of 52W HighCurrent price vs 52-week peak | +78.6% | +87.5% |
| RSI (14)Momentum oscillator 0–100 | 62.0 | 64.4 |
| Avg Volume (50D)Average daily shares traded | 25K | 6.8M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $324.00 |
| # AnalystsCovering analysts | — | 30 |
| Dividend YieldAnnual dividend ÷ price | — | +0.0% |
| Dividend StreakConsecutive years of raises | — | 0 |
| Dividend / ShareAnnual DPS | — | $0.07 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.1% |
COHR leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). POCI leads in 1 (Valuation Metrics). 1 tied.
POCI vs COHR: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is POCI or COHR a better buy right now?
For growth investors, Coherent, Inc.
(COHR) is the stronger pick with 23. 4% revenue growth year-over-year, versus -0. 1% for Precision Optics Corporation, Inc. (POCI). Analysts rate Coherent, Inc. (COHR) a "Buy" — based on 30 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — POCI or COHR?
Over the past 5 years, Coherent, Inc.
(COHR) delivered a total return of +401. 6%, compared to -7. 9% for Precision Optics Corporation, Inc. (POCI). Over 10 years, the gap is even starker: COHR returned +1546% versus POCI's +240. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — POCI or COHR?
By beta (market sensitivity over 5 years), Precision Optics Corporation, Inc.
(POCI) is the lower-risk stock at 0. 42β versus Coherent, Inc. 's 2. 82β — meaning COHR is approximately 568% more volatile than POCI relative to the S&P 500. On balance sheet safety, Precision Optics Corporation, Inc. (POCI) carries a lower debt/equity ratio of 17% versus 46% for Coherent, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — POCI or COHR?
By revenue growth (latest reported year), Coherent, Inc.
(COHR) is pulling ahead at 23. 4% versus -0. 1% for Precision Optics Corporation, Inc. (POCI). On earnings-per-share growth, the picture is similar: Coherent, Inc. grew EPS 71. 7% year-over-year, compared to -73. 5% for Precision Optics Corporation, Inc.. Over a 3-year CAGR, COHR leads at 20. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — POCI or COHR?
Coherent, Inc.
(COHR) is the more profitable company, earning 0. 8% net margin versus -30. 3% for Precision Optics Corporation, Inc. — meaning it keeps 0. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: COHR leads at 9. 4% versus -29. 1% for POCI. At the gross margin level — before operating expenses — COHR leads at 35. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — POCI or COHR?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is POCI or COHR better for a retirement portfolio?
For long-horizon retirement investors, Precision Optics Corporation, Inc.
(POCI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 42), +240. 0% 10Y return). Coherent, Inc. (COHR) carries a higher beta of 2. 82 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (POCI: +240. 0%, COHR: +1546%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between POCI and COHR?
These companies operate in different sectors (POCI (Healthcare) and COHR (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: POCI is a small-cap quality compounder stock; COHR is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.